Nuvama’s latest technical report identifies Bank of Maharashtra, Glenmark Pharmaceuticals, and Tata Technologies as key picks amid current market volatility. The brokerage outlines specific price targets and risk-management levels for these stocks, even as broader indices face pressure from rising oil prices and geopolitical concerns.
Nuvama Professional Clients Group has released a fresh technical analysis highlighting Bank of Maharashtra, Glenmark Pharmaceuticals, and Tata Technologies as potential opportunities. This report comes at a time when the broader Indian stock market is facing headwinds, with the Nifty index recently breaking a key support trendline due to rising global oil prices and increased geopolitical tensions in West Asia.
While the broader market remains cautious, the banking sector has shown relative resilience. The brokerage suggests that the Bank Nifty index remains a potential opportunity on dips as long as it stays above the 56,800 level. Investors are monitoring whether the Nifty index can reclaim its lost ground or if it might drift toward the 23,650 mark, making sector-specific stock selection a critical focus.
In the public sector banking space, Bank of Maharashtra is seen as a preferred choice. The stock has been trading sideways—a period known as consolidation—near its 20-day moving average, supported by high trading volumes. The brokerage has placed a target of Rs 88 for the stock, with a suggested exit or risk-management level set at Rs 78.
Glenmark Pharmaceuticals has also drawn attention following a breakout into record-high territory. After successfully retesting the 2,400 level, the stock has shown strength compared to the wider market. The report identifies a target price of Rs 2,700, with a suggested stop-loss level of Rs 2,340 for those managing risk.
Tata Technologies remains in focus as well, having shown a recovery since its March lows. The company is currently building on gains following a technical pattern identified in August, and the brokerage has set a price target of Rs 940, with a risk-management level at Rs 775.
Investors should note that these recommendations are based on technical indicators and market momentum rather than long-term fundamental performance. Market volatility remains high, and any failure to hold the specified risk-management levels, combined with broader index weakness, could impact the performance of these trades. The next important step for investors will be to monitor if these stocks can maintain their technical support levels while the Nifty index navigates its current volatility.